Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells

D. Trisciuoglio, C. Gabellini, M. Desideri, Y. Ragazzoni, T. De Luca, E. Ziparo, D. Del Bufalo

Research output: Contribution to journalArticlepeer-review

Abstract

In addition to act as an antiapoptotic protein, B-cell lymphoma (bcl)-2 can also promote tumor angiogenesis. In this context, we have previously demonstrated that under hypoxia bcl-2 promotes hypoxia-inducible factor-1 (HIF-1)-mediated vascular endothelial growth factor (VEGF) expression in melanoma and breast carcinoma. Here, we report on the role of the BH4 domain in bcl-2 functions, by showing that removal of or mutations at the BH4 domain abrogate the ability of bcl-2 to induce VEGF protein expression and transcriptional activity under hypoxia in human melanoma cells. We have also extended this observation to other human tumor histotypes, such as colon, ovarian and lung carcinomas. The involvement of BH4 on HIF-1α protein expression, stability, ubiquitination and HIF-1 transcriptional activity was also demonstrated in melanoma experimental model. Moreover, we validated the role of the BH4 domain of bcl-2 in the regulation of HIF-1/VEGF axis, demonstrating that BH4 peptide is sufficient to increase HIF-1α protein half-life impairing HIF-1α protein ubiquitination, and to enhance VEGF secretion in melanoma cells exposed to hypoxia. Finally, we found that the mechanism by which bcl-2 regulates HIF-1-mediated VEGF expression does not require BH1 and BH2 domains, and it is independent of antiapoptotic and prosurvival function of bcl-2.

Original languageEnglish
Pages (from-to)1024-1035
Number of pages12
JournalCell Death and Differentiation
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 2011

Keywords

  • bcl-2
  • BH domain
  • cancer
  • HIF-1
  • VEGF

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Fingerprint

Dive into the research topics of 'Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells'. Together they form a unique fingerprint.

Cite this